rs1611131
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000787.4(DBH):c.1563-5A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 1,613,268 control chromosomes in the GnomAD database, including 67,034 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000787.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DBH | NM_000787.4 | c.1563-5A>G | splice_region_variant, intron_variant | ENST00000393056.8 | NP_000778.3 | |||
DBH-AS1 | NR_102735.1 | n.282+62T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DBH | ENST00000393056.8 | c.1563-5A>G | splice_region_variant, intron_variant | 1 | NM_000787.4 | ENSP00000376776.2 | ||||
DBH-AS1 | ENST00000425189.1 | n.187+62T>C | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.257 AC: 38991AN: 151990Hom.: 5521 Cov.: 33
GnomAD3 exomes AF: 0.284 AC: 71208AN: 250752Hom.: 11158 AF XY: 0.275 AC XY: 37307AN XY: 135638
GnomAD4 exome AF: 0.284 AC: 415076AN: 1461160Hom.: 61514 Cov.: 39 AF XY: 0.280 AC XY: 203216AN XY: 726890
GnomAD4 genome AF: 0.256 AC: 39006AN: 152108Hom.: 5520 Cov.: 33 AF XY: 0.257 AC XY: 19111AN XY: 74364
ClinVar
Submissions by phenotype
Orthostatic hypotension 1 Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at